optimal chemotherapy combinations in tnbc gbrca subtypes
Published 3 years ago • 105 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
5:21
optimal neoadjuvant and adjuvant therapy for patients with early tnbc
-
2:09
triplet combination of chemotherapy, cd40 agonist, and flt3 ligand in triple-negative breast cancer
-
1:24
combining chemotherapy, cd40 agonist, and flt3 ligand in triple-negative breast cancer
-
1:29
lig1 deletion predicts chemotherapy resistance in triple-negative breast cancer
-
1:30
begonia: durvalumab combinations in advanced tnbc
-
3:26
chemo-immunotherapy for tnbc
-
4:38
alice: atezolizumab immunogenic chemotherapy in metastatic tnbc
-
1:30
keynote-355: hrqol unaffected by the addition of pembrolizumab to chemotherapy for tnbc
-
2:05
treatment advances in tnbc
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:12
novel immune checkpoint inhibitor combinations for tnbc treatment
-
8:52
real-world outcomes of her2 and tnbc patients recieving neoadjuvant chemotherapy
-
3:45
barbican: ipatasertib plus atezolizumab and chemotherapy in tnbc
-
0:10
finished chemo and still don't feel like yourself
-
0:51
challenges in the treatment of mtnbc
-
2:01
ascent: sacituzumab govitecan outperforms chemo in black patients with tnbc
-
0:13
chemo #breastcancer #tnbc #chemotherapy #chemo #breastcancersurvivor #cancerjourney #cancer #fyp
-
1:58
promising novel approaches to the treatment of tnbc
-
1:04
are combination approaches the way forward for treating patients with triple-negative breast cancer?